Regen BioPharma Inc cotiza a 0.00 USD y tiene una capitalización bursátil de $167528. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. The company engages in identifying small molecules that inhibit or express NR2F6, leading to immune cell activation for oncology applications and immune cell suppression for autoimmune diseases. It also develops …
| Métrica | RGBP | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -143.1% | -38.6% | -104.5% |
| Net Margin | -538.8% | -33.6% | -505.2% |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -464.1% | -32.0% | -432.1% |
| Current Ratio | 0.04 | 2.84 | -2.80 |
| Debt / Equity | — | 0.28 | — |